Definium Therapeutics Scores Another Win For Its LSD-Based Drug; Shares Pop
AI Generated Image

Definium Therapeutics Scores Another Win For Its LSD-Based Drug; Shares Pop

Investor's Business Daily business

Key Points:

  • Investor’s Business Daily provides information for educational purposes only and does not offer investment advice or recommendations to buy or sell securities.
  • The information is sourced from what are believed to be reliable sources, but accuracy, timeliness, and suitability are not guaranteed.
  • Past investment performance mentioned is not indicative of future results, and authors may hold positions in the stocks they discuss.
  • Real-time prices are provided by Nasdaq Last Sale but do not cover all markets; ownership and estimate data come from LSEG and FactSet respectively.
  • All trademarks and content are owned by Investor’s Business Daily, LLC, with terms of use governing the service, and information is subject to change without notice.

Trending Business

Trending Technology

Trending Health